Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT.
作者信息
Yang Yingying, Hu Yongxian, Huang He
机构信息
Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, China.
出版信息
Regen Ther. 2019 Jul 15;11:139-142. doi: 10.1016/j.reth.2019.06.006. eCollection 2019 Dec.
Abstract
摘要
Zotero 插件